Directorio

We are doing this study to improve care for people with cleft lip and/or cleft palate.

If you choose to join this study, you will:<ul>
<li>Give a saliva sample</li>
<li>Have a genetic test using the Color Genomics 30 gene hereditary panel test</li></ul>

We are doing this study to find out if neratinib combined with palbociclib is better than neratinib alone when it comes to treating HER2-positive tumors.

We are doing this study to learn more about how right hemisphere brain damage (RHD) from a stroke can affect people's ability to communicate. We want to improve treatments to help stroke survivors regain their ability to communicate.

We are doing this study to find out if adding a drug called tucatinib to the usual treatment of T-DM1 on its own can help prevent breast cancer from returning.

We are doing this study to learn if SAPIEN 3 valve system is safe and will work with adults and children who have a dysfunctional right ventricular outflow tract (RVOT) conduit or have an implanted valve in the pulmonic position.

We are doing this study to compare the study drug, lutetium-177 edotreotide, to existing standard-of-care therapies.

We want to find out if a study drug called larotrectinib is an effective treatment for brain tumors in children and young adults. We want to learn how well it works to shrink brain tumors when used alone or when given with standard chemotherapy or after radiation therapy.